Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally induced septic shock in rats

In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by s...

Full description

Saved in:
Bibliographic Details
Published inAnesth Analg Vol. 99; no. 1; pp. 212 - 220
Main Authors Kadoi, Yuji, Goto, Fumio
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Ovid Technologies (Wolters Kluwer Health) 01.07.2004
International Anesthesia Research Society
Lippincott
Subjects
Online AccessGet full text
ISSN0003-2999
DOI10.1213/01.ane.0000118111.94913.22

Cover

Abstract In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groupscontrol, sham, CLP, and CLP + the selective iNOS inhibitor l-N 6-(1-iminoethyl)-lysine (l-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 hcontrol, 0.3 ± 0.05; sham, 0.3 ± 0.1; CLP, 1.3 ± 0.08*; CLP + l-NIL, 0.33 ± 0.1 fmol · mg−1 · min−1; at 24 hcontrol, 0.27 ± 0.08; sham, 0.31 ± 0.1; CLP, 1.0 ± 0.3*; CLP + l-NIL, 0.34 ± 0.1 fmol · mg−1 · min−1; mean ± sd; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 hcontrol, 6.7 ± 0.4; sham, 6.7 ± 0.5; CLP, 11.2 ± 2.8*; CLP + l-NIL, 7.52 ± 0.5 densitometric units; means ± sd; *P < 0.01). In contrast, in both the CLP and CLP + l-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction.
AbstractList In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groupscontrol, sham, CLP, and CLP + the selective iNOS inhibitor l-N 6-(1-iminoethyl)-lysine (l-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 hcontrol, 0.3 ± 0.05; sham, 0.3 ± 0.1; CLP, 1.3 ± 0.08*; CLP + l-NIL, 0.33 ± 0.1 fmol · mg−1 · min−1; at 24 hcontrol, 0.27 ± 0.08; sham, 0.31 ± 0.1; CLP, 1.0 ± 0.3*; CLP + l-NIL, 0.34 ± 0.1 fmol · mg−1 · min−1; mean ± sd; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 hcontrol, 6.7 ± 0.4; sham, 6.7 ± 0.5; CLP, 11.2 ± 2.8*; CLP + l-NIL, 7.52 ± 0.5 densitometric units; means ± sd; *P < 0.01). In contrast, in both the CLP and CLP + l-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction.
In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groups: control, sham, CLP, and CLP + the selective iNOS inhibitor L-N6-(1-iminoethyl)-lysine (L-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 h: control, 0.3 +/- 0.05; sham, 0.3 +/- 0.1; CLP, 1.3 +/- 0.08*; CLP + L-NIL, 0.33 +/- 0.1 fmol x mg(-1) x min(-1); at 24 h: control, 0.27 +/- 0.08; sham, 0.31 +/- 0.1; CLP, 1.0 +/- 0.3*; CLP + L-NIL, 0.34 +/- 0.1 fmol x mg(-1) x min(-1); mean +/- SD; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 h: control, 6.7 +/- 0.4; sham, 6.7 +/- 0.5; CLP, 11.2 +/- 2.8*; CLP + L-NIL, 7.52 +/- 0.5 densitometric units; means +/- SD; *P < 0.01). In contrast, in both the CLP and CLP + L-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction.In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groups: control, sham, CLP, and CLP + the selective iNOS inhibitor L-N6-(1-iminoethyl)-lysine (L-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 h: control, 0.3 +/- 0.05; sham, 0.3 +/- 0.1; CLP, 1.3 +/- 0.08*; CLP + L-NIL, 0.33 +/- 0.1 fmol x mg(-1) x min(-1); at 24 h: control, 0.27 +/- 0.08; sham, 0.31 +/- 0.1; CLP, 1.0 +/- 0.3*; CLP + L-NIL, 0.34 +/- 0.1 fmol x mg(-1) x min(-1); mean +/- SD; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 h: control, 6.7 +/- 0.4; sham, 6.7 +/- 0.5; CLP, 11.2 +/- 2.8*; CLP + L-NIL, 7.52 +/- 0.5 densitometric units; means +/- SD; *P < 0.01). In contrast, in both the CLP and CLP + L-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction.
In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal ligation and puncture (CLP) and examined whether selective iNOS inhibition can prevent the hemodynamic and neurological changes induced by sepsis. Male Wistar rats were randomly divided into four groups: control, sham, CLP, and CLP + the selective iNOS inhibitor L-N6-(1-iminoethyl)-lysine (L-NIL). Septic shock was induced in the rats by CLP under pentobarbital anesthesia, and then we measured hemodynamic variables, neurological indicators, blood gases, plasma levels of nitrate/nitrite (an indicator of the biosynthesis of NO), and brain iNOS activity and nitrotyrosine levels after 1, 6, 12, and 24 h. Plasma nitrite was increased at 12 and 24 h in the CLP group. The activity of iNOS in the brain was increased at 12 and 24 h after CLP (at 12 h: control, 0.3 +/- 0.05; sham, 0.3 +/- 0.1; CLP, 1.3 +/- 0.08*; CLP + L-NIL, 0.33 +/- 0.1 fmol x mg(-1) x min(-1); at 24 h: control, 0.27 +/- 0.08; sham, 0.31 +/- 0.1; CLP, 1.0 +/- 0.3*; CLP + L-NIL, 0.34 +/- 0.1 fmol x mg(-1) x min(-1); mean +/- SD; *P < 0.05). Brain nitrotyrosine was increased at 24 h after CLP (at 24 h: control, 6.7 +/- 0.4; sham, 6.7 +/- 0.5; CLP, 11.2 +/- 2.8*; CLP + L-NIL, 7.52 +/- 0.5 densitometric units; means +/- SD; *P < 0.01). In contrast, in both the CLP and CLP + L-NIL groups, the consciousness reflex was significantly decreased at 24 h after CLP. Selective iNOS inhibition restored the hemodynamic changes induced by sepsis but could not improve neurological dysfunction.
Author KADOI Y
AuthorAffiliation Department of Intensive Care, Gunma University, School of Medicine, Gunma, Japan; and †Department of Anesthesiology, Gunma University, Graduate School of Medicine, Gunma, Japan
AuthorAffiliation_xml – name: Department of Intensive Care, Gunma University, School of Medicine, Gunma, Japan; and †Department of Anesthesiology, Gunma University, Graduate School of Medicine, Gunma, Japan
Author_xml – sequence: 1
  givenname: Yuji
  surname: Kadoi
  fullname: Kadoi, Yuji
  organization: Department of Intensive Care, Gunma University, School of Medicine, Gunma, Japan; and †Department of Anesthesiology, Gunma University, Graduate School of Medicine, Gunma, Japan
– sequence: 2
  givenname: Fumio
  surname: Goto
  fullname: Goto, Fumio
BackLink https://cir.nii.ac.jp/crid/1573105976154161536$$DView record in CiNii
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15913235$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15281532$$D View this record in MEDLINE/PubMed
BookMark eNqNkctu1DAUhrMoohd4BWQhYEUGX5OYFVVVWqQKFsA6cuwTxtSxB9uhndfhSXFmBhWxwpJt2f7O__ucc1od-eChqp4TvCKUsDeYrJSHFS6DkI4QspJcErai9Kg6KZesplLK4-o0pe8Lg7vmcXVMBO2IYPSk-vUZHOhsfwKy3szaDg6QtzlajcK9Ncv12g422-CRVh5FSDlEQGuYgtl6NVmdXqNhzsgESMiHjOy0iaEIephjcOGb1cohs03j7PVOx3oE9xuIdgKflXPbvTcYlGCTi3NaB327YFHl9KR6NCqX4OlhP6u-vr_8cnFd33y6-nBxflNrTiSteccHTBvejYMcRdsNDAsztmzElFLDpCkPHDMjGyzIIIE0THJDRlB6VA0V7Kx6tdctv_8xlzT7ySYNzpUChzn1TdMK3Ha8gM8O4DxMYPpNSUTFbf-nqgV4eQBUKrmPUXlt019c6RBli-PbPadjSCnC-IDgfmlvj0l__vGyf2hvv2tvTxeTd_8Ea5vVUt8clXX_J8H3EnfBZYjp1s13EPs1KJfXuwgsmKwpxhy35VCXyZewF_swb20xXVYiWkawkG1DBCdlYQ37DZPbywI
CODEN AACRAT
CitedBy_id crossref_primary_10_1016_j_ccc_2007_10_001
crossref_primary_10_1097_CPM_0b013e3181a3a4bf
crossref_primary_10_1186_2110_5820_3_15
crossref_primary_10_2217_fnl_10_62
crossref_primary_10_1186_s12871_021_01436_0
crossref_primary_10_1016_j_anrea_2019_03_002
crossref_primary_10_1016_j_biopha_2018_09_162
crossref_primary_10_1016_j_exer_2005_08_011
crossref_primary_10_1007_s00540_010_0934_1
crossref_primary_10_1097_CCM_0b013e3181760c4b
crossref_primary_10_1007_s11910_016_0623_z
crossref_primary_10_1007_s13546_010_0118_x
crossref_primary_10_1586_eri_12_159
crossref_primary_10_1097_WCO_0b013e32832b3101
crossref_primary_10_1007_s00134_007_0622_2
crossref_primary_10_1016_j_ejps_2015_01_001
crossref_primary_10_1038_jcbfm_2009_215
crossref_primary_10_1016_j_freeradbiomed_2011_06_012
crossref_primary_10_1111_nyas_13985
crossref_primary_10_1586_ers_09_39
crossref_primary_10_1016_j_pharmthera_2009_05_005
crossref_primary_10_23736_S0375_9393_20_13826_4
crossref_primary_10_1176_jnp_23_3_jnp237
crossref_primary_10_1002_ardp_200800192
crossref_primary_10_1007_s10753_011_9359_8
crossref_primary_10_1097_CCM_0b013e3181b6ed58
crossref_primary_10_1097_CCM_0000000000000301
crossref_primary_10_1016_j_bbi_2019_10_012
crossref_primary_10_1097_SHK_0b013e31804d452d
crossref_primary_10_1111_j_1399_6576_2007_01573_x
crossref_primary_10_1093_bja_aei106
crossref_primary_10_1007_s00540_006_0428_3
crossref_primary_10_1016_j_brainres_2010_07_049
crossref_primary_10_1097_01_CCM_0000187010_14426_CC
crossref_primary_10_1002_ame2_12167
Cites_doi 10.1164/ajrccm.161.6.9812004
10.1002/jnr.490400214
10.1152/ajpcell.1998.275.2.C416
10.1097/00024382-199610000-00004
10.1016/S0306-3623(96)00410-7
10.1097/00000539-200103000-00025
10.1097/00003246-200008000-00057
10.1097/00003246-199302001-00005
10.1006/jsre.1996.0153
10.1152/ajpcell.1996.271.5.C1424
10.1172/JCI119551
10.1016/0361-9230(96)00159-1
10.1111/j.1476-5381.1996.tb15397.x
10.1159/000054305
10.1016/0022-4804(80)90037-2
10.1006/jsre.2002.6524
10.1021/jm00049a007
10.1038/375408a0
10.1016/S0006-8993(99)01124-5
10.1097/00024382-199608000-00001
10.1080/10715760290032557
10.1097/00024382-200116040-00013
10.1038/nm0596-581
10.1097/00003246-199602000-00020
10.1046/j.1471-4159.2000.0752144.x
ContentType Journal Article
Copyright International Anesthesia Research Society
2004 INIST-CNRS
Copyright_xml – notice: International Anesthesia Research Society
– notice: 2004 INIST-CNRS
DBID RYH
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1213/01.ane.0000118111.94913.22
DatabaseName CiNii Complete
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EndPage 220
ExternalDocumentID 15281532
15913235
10_1213_01_ANE_0000118111_94913_22
00000539-200407000-00042
30012760614
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.-D
.55
.GJ
.XZ
.Z2
01R
026
0R~
1CY
1J1
23M
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAUEB
AAWTL
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABKPX
ABOCM
ABPPZ
ABPXF
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACLED
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFMBP
AFMFG
AFNMH
AFSOK
AFUWQ
AGINI
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AHXIK
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJRGT
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BOYCO
BQLVK
BS7
C1A
C45
CS3
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRP
FW0
GNXGY
GQDEL
GX1
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
L7B
M18
MZP
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB4
OCUKA
ODA
ODMTH
OHYEH
OK1
OL1
OLG
OLH
OLL
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PONUX
R58
RIG
RLZ
RYH
S4R
S4S
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YOC
YQJ
ZFV
ZGI
ZXP
ZZMQN
AAYXX
ADSXY
CITATION
IQODW
ACIJW
AWKKM
CGR
CUY
CVF
DIK
ECM
EIF
NPM
OJAPA
OLW
PKN
7X8
ADKSD
ID FETCH-LOGICAL-c4192-484b02648fb9f578b305df73f0222d39d8fb403d96051b9e16394d1feacfa6253
ISSN 0003-2999
IngestDate Mon Sep 08 16:31:05 EDT 2025
Wed Feb 19 02:33:59 EST 2025
Mon Jul 21 09:13:28 EDT 2025
Thu Apr 24 22:53:05 EDT 2025
Tue Aug 12 03:53:07 EDT 2025
Fri May 16 03:50:31 EDT 2025
Thu Jun 26 21:56:59 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Infection
Vertebrata
Mammalia
Rat
Animal
Nitric oxide
Rodentia
Anesthesia
Hemodynamics
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4192-484b02648fb9f578b305df73f0222d39d8fb403d96051b9e16394d1feacfa6253
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15281532
PQID 66750784
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_66750784
pubmed_primary_15281532
pascalfrancis_primary_15913235
crossref_primary_10_1213_01_ANE_0000118111_94913_22
crossref_citationtrail_10_1213_01_ANE_0000118111_94913_22
wolterskluwer_health_00000539-200407000-00042
nii_cinii_1573105976154161536
PublicationCentury 2000
PublicationDate 2004-July-01
PublicationDateYYYYMMDD 2004-07-01
PublicationDate_xml – month: 07
  year: 2004
  text: 2004-July-01
  day: 01
PublicationDecade 2000
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Anesth Analg
PublicationTitleAlternate Anesth Analg
PublicationYear 2004
Publisher Ovid Technologies (Wolters Kluwer Health)
International Anesthesia Research Society
Lippincott
Publisher_xml – name: Ovid Technologies (Wolters Kluwer Health)
– name: International Anesthesia Research Society
– name: Lippincott
References Thiemermann (R5-42-20110423) 1997; 29
Van Dam (R9-42-20110423) 1995; 40
Beckman (R12-42-20110423) 1996; 271
Schwartz (R19-42-20110423) 1997; 100
Satta (R24-42-20110423) 1998; 67
Vincent (R6-42-20110423) 2000; 161
Strunk (R14-42-20110423) 2001; 92
Javeshghani (R16-42-20110423) 2001; 16
Wichterman (R13-42-20110423) 1980; 29
Harada (R11-42-20110423) 1999; 821
Papadopoulos (R25-42-20110423) 2000; 28
Szabo (R4-42-20110423) 1996; 6
Liu (R27-42-20110423) 2000; 75
Kadoi (R2-42-20110423) 1996; 24
Szabo (R7-42-20110423) 1996; 41
Baechtold (R8-42-20110423) 2001; 16
Wong (R10-42-20110423) 1996; 2
Ruetten (R23-42-20110423) 1996; 118
Voigt (R26-42-20110423) 2002; 36
Gunnett (R22-42-20110423) 1998; 275
Moore (R15-42-20110423) 1994; 23
Ghosh (R1-42-20110423) 1993; 21
Vromen (R20-42-20110423) 1996; 6
Kadoi (R17-42-20110423) 2002; 108
Wei (R21-42-20110423) 1995; 375
Kadoi (R3-42-20110423) 1996; 61
References_xml – volume: 161
  start-page: 1781
  year: 2000
  ident: R6-42-20110423
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.161.6.9812004
– volume: 40
  start-page: 251
  year: 1995
  ident: R9-42-20110423
  publication-title: J Neurosci Res
  doi: 10.1002/jnr.490400214
– volume: 275
  start-page: H416
  year: 1998
  ident: R22-42-20110423
  publication-title: Am J Physiol
  doi: 10.1152/ajpcell.1998.275.2.C416
– volume: 6
  start-page: 248
  year: 1996
  ident: R20-42-20110423
  publication-title: Shock
  doi: 10.1097/00024382-199610000-00004
– volume: 29
  start-page: 159
  year: 1997
  ident: R5-42-20110423
  publication-title: Gen Pharmacol
  doi: 10.1016/S0306-3623(96)00410-7
– volume: 16
  start-page: 137
  year: 2001
  ident: R8-42-20110423
  publication-title: hock
– volume: 92
  start-page: 681
  year: 2001
  ident: R14-42-20110423
  publication-title: Anesth Analg
  doi: 10.1097/00000539-200103000-00025
– volume: 28
  start-page: 3019
  year: 2000
  ident: R25-42-20110423
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200008000-00057
– volume: 21
  start-page: S19
  year: 1993
  ident: R1-42-20110423
  publication-title: Crit Care Med
  doi: 10.1097/00003246-199302001-00005
– volume: 61
  start-page: 496
  year: 1996
  ident: R3-42-20110423
  publication-title: J Surg Res
  doi: 10.1006/jsre.1996.0153
– volume: 271
  start-page: C1424
  year: 1996
  ident: R12-42-20110423
  publication-title: Am J Physiol
  doi: 10.1152/ajpcell.1996.271.5.C1424
– volume: 100
  start-page: 439
  year: 1997
  ident: R19-42-20110423
  publication-title: J Clin Invest
  doi: 10.1172/JCI119551
– volume: 41
  start-page: 131
  year: 1996
  ident: R7-42-20110423
  publication-title: Brain Res Bull
  doi: 10.1016/0361-9230(96)00159-1
– volume: 118
  start-page: 261
  year: 1996
  ident: R23-42-20110423
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.1996.tb15397.x
– volume: 67
  start-page: 109
  year: 1998
  ident: R24-42-20110423
  publication-title: Neuroendocrinology
  doi: 10.1159/000054305
– volume: 29
  start-page: 189
  year: 1980
  ident: R13-42-20110423
  publication-title: J Surg Res
  doi: 10.1016/0022-4804(80)90037-2
– volume: 108
  start-page: 69
  year: 2002
  ident: R17-42-20110423
  publication-title: J Surg Res
  doi: 10.1006/jsre.2002.6524
– volume: 23
  start-page: 3886
  year: 1994
  ident: R15-42-20110423
  publication-title: J Med Chem
  doi: 10.1021/jm00049a007
– volume: 375
  start-page: 408
  year: 1995
  ident: R21-42-20110423
  publication-title: Nature
  doi: 10.1038/375408a0
– volume: 821
  start-page: 322
  year: 1999
  ident: R11-42-20110423
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(99)01124-5
– volume: 6
  start-page: 79
  year: 1996
  ident: R4-42-20110423
  publication-title: Shock
  doi: 10.1097/00024382-199608000-00001
– volume: 36
  start-page: 735
  year: 2002
  ident: R26-42-20110423
  publication-title: Free Radic Res
  doi: 10.1080/10715760290032557
– volume: 16
  start-page: 304
  year: 2001
  ident: R16-42-20110423
  publication-title: Shock
  doi: 10.1097/00024382-200116040-00013
– volume: 2
  start-page: 581
  year: 1996
  ident: R10-42-20110423
  publication-title: Nat Med
  doi: 10.1038/nm0596-581
– volume: 24
  start-page: 298
  year: 1996
  ident: R2-42-20110423
  publication-title: Crit Care Med
  doi: 10.1097/00003246-199602000-00020
– volume: 75
  start-page: 2144
  year: 2000
  ident: R27-42-20110423
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2000.0752144.x
SSID ssj0001086
Score 1.9599428
Snippet In this study, we evaluated the time course of changes in inducible nitric oxide synthase (iNOS) in the brain by using the rat model of sepsis induced by cecal...
SourceID proquest
pubmed
pascalfrancis
crossref
wolterskluwer
nii
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 212
SubjectTerms Anesthesia
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Blood Pressure
Blood Pressure - drug effects
Blotting, Western
Calcium
Calcium - physiology
Cecum
Cecum - injuries
Cecum - physiology
Cerebral Cortex
Cerebral Cortex - metabolism
Enzyme Inhibitors
Enzyme Inhibitors - therapeutic use
Heart Rate
Heart Rate - drug effects
Hemodynamics
Hemodynamics - drug effects
Interleukin-1
Interleukin-1 - metabolism
Lysine
Lysine - analogs & derivatives
Lysine - therapeutic use
Male
Medical sciences
Nervous System Diseases
Nervous System Diseases - drug therapy
Nervous System Diseases - etiology
Nitric Oxide
Nitric Oxide - metabolism
Nitric Oxide Synthase
Nitric Oxide Synthase - antagonists & inhibitors
Nitric Oxide Synthase Type II
Rats
Rats, Wistar
Shock, Septic
Shock, Septic - complications
Shock, Septic - physiopathology
Tumor Necrosis Factor-alpha
Tumor Necrosis Factor-alpha - metabolism
Tyrosine
Tyrosine - analogs & derivatives
Tyrosine - metabolism
Title Selective inducible nitric oxide inhibition can restore hemodynamics, but does not improve neurological dysfunction in experimentally induced septic shock in rats
URI https://cir.nii.ac.jp/crid/1573105976154161536
https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00000539-200407000-00042
https://www.ncbi.nlm.nih.gov/pubmed/15281532
https://www.proquest.com/docview/66750784
Volume 99
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6l5cIFgXgFaNkDt-AQr9dJ9hhBUQHRHEil3Czb61UNrY3iWFB-CWd-Kd-sn4EiCodYiZPddTSf57H-ZoaxZ8IYejqlHBNNQkfOReyoRIWO1m5kYFImWtOG_vuT6fGpfLv214PB9x5rqdxG4_jblXkl_yNVnINcKUv2HyTbTooTeA_54ggJ43gtGX-wTWyI-4PIuoxTyoLCLUrk-Pxrqun0WRpZUhaxu0Yb20YmgXd4keuqFb0VY1RuRzpPilGWbylvcpNjSlvpstGM-rIgC9gwI_t9Ac4vHbs6PNeCKDLxqDiDkrWJMmFVJ6otcwu9CoezqBLB8KImI0XaWoZ3i1fLN9YolB_Tlhm0XC2ti11eVJyxdpNCtoTWepOiLTaxo4upi1zVHqnRxfWnPuYaxSp6NlrYBLrf1b9wPZvSMA6zxFampLRa1x0rqVxvLERn9JoH_b_YwpahCC8Pcbrn77EbYgavjNLI1x15iPpTNb0Y6T_U5Wyx_os_r77j-uxlaUpE3LCAFE3VROWqKAe_-ZITcaL4ZPMmet7P6ja7VYctfFFh8A4bJNld9qPFH2_xxyv8cYs_3uGPA3-8xh_v4-85B_o4oY8DfbxGH--jj_fQhyn51ejjFfq4RR_9jNB3j52-Plq9PHbqnh9OTHwEaAsZTYh1aSJlYE0i2CNtZp6hjQntKY0v5MTTCLx9N1IJwgkltWvgP5gQsbx3n-1neZY8ZDyUBsOlmYUqktNQKiH1zMz9SRj7IhbhkKlGHEFcF8SnviznAQXGEGUwcYPFyVHQiTKwogyEGDKvHfu5KgtzrVEHkDoWo6PrzzwKbmaIKaSNu6ZDdriDh27qGo1D9rQBSAAzQM_2gLW8LIIpAn94-3LIHlS46Y0Vc0yOxZ0dIAVVorW9TlhiZTUrHIC60oR49LeLecxudrf6E7a_3ZTJATz0bXRob5afzSDlNQ
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selective+inducible+nitric+oxide+inhibition+can+restore+hemodynamics%2C+but+does+not+improve+neurological+dysfunction+in+experimentally-induced+septic+shock+in+rats&rft.jtitle=Anesthesia+and+analgesia&rft.au=KADOI%2C+Yuji&rft.au=GOTO%2C+Fumio&rft.date=2004-07-01&rft.pub=Lippincott&rft.issn=0003-2999&rft.volume=99&rft.issue=1&rft.spage=212&rft.epage=220&rft_id=info:doi/10.1213%2F01.ane.0000118111.94913.22&rft.externalDBID=n%2Fa&rft.externalDocID=15913235
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-2999&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-2999&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-2999&client=summon